Drug and Substance Abuse
Drug Abuse: a National Epidemic
The abuse of drugs or other substances, whether they are illegal drugs or prescription opioid drugs, alcohol or tobacco is one of the nation's most pressing public health issues. According to a report published by the Substance Abuse and Mental Health Services Administration (SAMHSA) in 2022, 70.3 million people aged 12 or older (or 24.9%) used illicit drugs in the past year.
In young people, the use of illicit substances in 2023 continued to hold steady below the pre-pandemic levels reported in 2020, but more young people are dying from drug overdoses, largely attributed to illicit fentanyl, a potent synthetic drug that may be contaminated with other toxic substances.
Drug abuse occurs when people willingly consume illegal substances or legal, prescription drugs for the purpose of altering their mood, or getting “high”. Regular drug abuse may lead to drug addiction or other bodily harm. Drug abuse usually involves selling, buying or abusing these substances, which can lead to arrest, criminal charges, and imprisonment.
The term “drug abuse” is often associated with illegal drugs such as cocaine, heroin, or LSD. More recently, dangerous designer drugs such as bath salts (cathinones) or club drugs such as ecstasy (MDMA) have become increasingly popular. And even legal substances such as tobacco and alcohol are linked with dangerous abuse. Marijuana, while illegal according to federal law, is now legal for recreational or medical use in multiple states.
- Designer drugs are synthetic chemicals altered in often unknown ways to produce substances that may be more potent, and frequently more dangerous. Designer drugs may resemble the effects of other illegal drugs, because the chemical formula of a designer drug is manipulated, they often cannot be classified as illegal until state or federal regulations are changed.
- Club drugs might be used by youth in all-night “rave” or dance parties, at bars and at concerts for their psychoactive effects.
- Alcohol and tobacco
- Prescription opioids
- Fentanyl, carfentanil and nitazenes (ISO) found in street drugs, often unknown to the user, and may lead to overdose and death.
Another synthetic opioid group called the nitazenes (specifically, isotonitazene or "ISO") was seen in some areas in 2019. It is reportedly as deadly as fentanyl, but not as widely known. Nitazenes are not approved prescription products and appear to be smuggled into the U.S. from China. Like fentanyl, it is being mixed into other drugs that are sold on the streets and can lead to overdose and death.
ISO is often mixed with street heroin, or pressed into counterfeit pills sold on the streets that may resemble prescription drugs, like counterfeit Dilaudid 'M-8' tablets and oxycodone 'M30' tablets. In powder form, ISO appears yellow, brown, or off-white in color.
Abused substances are not always illegal
Drug abuse can also occur with legal prescription drugs used in illegal ways. For example, the level of prescription opioid (narcotics) abuse in the U.S. surpasses the abuse of many illegal drugs. The unlawful use of steroids as performance enhancing drugs like anabolic steroids seen in college-level, Olympic and professional sports has resulted in a unique set of international anti-doping standards.
- Alcohol and cigarette tobacco (nicotine) use, remain as some of the top abused substances in the U.S. Increases in alcohol use were seen in teens in the 12th grade, returning to pre-pandemic levels in 2022 (with 51.9% of 12th graders reporting alcohol use in the past year).
- Nicotine vaping remained stable, with 27.3% of 12th graders reporting vaping nicotine in the past year.
Ultimately, abuse of these substances can lead to serious outcomes, including:
- Alcoholism
- Chronic liver disease like cirrhosis
- Liver cancer
- Chronic Obstructive Pulmonary Disease
- Lung cancer
- Other cancer types
- Overdose
- Death
Veterinary medicines
Increasingly, veterinary medicines are being abused or included in street drugs For example, there are reports of contamination of illegal drugs with xylazine (known as "tranq"), an FDA-approved, non-opioid animal tranquilizer and pain reliever. It may be diverted from the legal animal supply or illicitly produced. The are no approved uses of xylazine for humans.
Xylazine is not an opioid, but is sometimes added to drugs of abuse, like the opioids fentanyl or heroin, to prolong the euphoric effect, but users may not be aware they are being exposed. Overdose deaths due to xylazine have increased in recent years, and treatment with naloxone may not reverse its lethal effects.
Overview of drugs of abuse
The following documents detail common drugs or other substances of abuse, but do NOT include all possible abused prescription drugs, illicit drugs or their chemical counterparts.
This is not all the information you need to know about illicit drugs and substance abuse and does not take the place of your healthcare provider's directions. Discuss this information and any questions you have with your doctor or other health care provider.
- Bath Salts
- Cannabis
- Cocaine
- Devil's Breath
- Ecstasy
- GHB
- Gray Death
- Hashish (Hash)
- Heroin
- Ketamine
- Krokodil
- LSD
- Marijuana
- MDMA (Ecstasy, Molly)
- Mescaline (Peyote)
- Opium
- PCP (Phencyclidine)
- Psilocybin (Magic Mushrooms)
- Quaaludes
- Rohypnol
- Speed (methamphetamine)
- Synthetic Cannabinoids (Synthetic Marijuana, Spice, K2)
- TCP (Tenocyclidine)
- Tianeptine
- U-47700 (Pink)
- Xylazine (Tranq Dope)
Learn more
Treatment options
Care guides
Sources
- Reported drug use among adolescents continued to hold below pre-pandemic levels in 2023. National Institute on Drug Abuse (NIDA). NIH. Accessed Sept 30, 2024 at https://nida.nih.gov/news-events/news-releases/2023/12/reported-drug-use-among-adolescents-continued-to-hold-below-pre-pandemic-levels-in-2023
- FDA alerts health care professionals of risks to patients exposed to xylazine in illicit drugs. Nov. 8, 2022. U.S. Food and Drug Administration (FDA). Accessed April 26, 2024 at https://www.fda.gov/drugs/drug-safety-and-availability/fda-alerts-health-care-professionals-risks-patients-exposed-xylazine-illicit-drugs
- National Institute of Drug Abuse (NIDA). Most reported substance use among adolescents held steady in 2022. December 15, 2022. Retrieved Sept 30, 2024 from nida.nih.gov/news-events/news-releases/2022/12/most-reported-substance-use-among-adolescents-held-steady-in-2022
- HHS, SAMHSA Release 2022 National Survey on Drug Use and Health Data. SAMHSA, HHS. Nov. 13, 2023. Accessed Sept 30, 2024 at https://www.samhsa.gov/newsroom/press-announcements/20231113/hhs-samhsa-release-2022-nsduh-data
- New, Dangerous Synthetic Opioid in D.C., Emerging in Tri-State Area. DEA Washington, DC Division - Public Information Office. Accessed Sept 30, 2024 at https://www.dea.gov/stories/2022/2022-06/2022-06-01/new-dangerous-synthetic-opioid-dc-emerging-tri-state-area
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.